First AD

Second AD

Disease Severity and Delays in Treatment in CSU

Video content above is prompted by the following:

How frequently do patients receive a delayed diagnosis? What are the implications associated with this delay?

Evolving Perspectives and Treatment Strategies in Chronic Spontaneous Urticaria 

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Disease severity in chronic spontaneous urticaria (CSU) is assessed using tools like the Urticaria Activity Score over 7 days (UAS7) and the Urticaria Control Test (UCT). These tools help quantify symptom severity and control, guiding treatment decisions. Delayed diagnosis is common, often due to symptom overlap with other conditions and lack of awareness. This delay can lead to prolonged patient suffering, increased healthcare costs, and potential worsening of the condition. Early and accurate diagnosis is crucial for effective management and improved patient outcomes.

Panelists discuss how disease severity in chronic spontaneous urticaria (CSU) is assessed using tools such as the Urticaria Activity Score over 7 days (UAS7) and the Urticaria Control Test (UCT), while also addressing the frequency of delayed diagnoses and the significant implications for condition management and patient quality of life.

Bringing CSU Back Under The House of Dermatology

Understanding the Chronicity of CSU

The Psychosocial Impact of CSU